MetaVia, Inc. (MTVA)
1.76
-0.08
(-4.35%)
USD |
NASDAQ |
Sep 04, 16:00
1.76
0.00 (0.00%)
After-Hours: 16:03
MetaVia Debt to Equity Ratio : 0.0259 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0259 |
| March 31, 2026 | 0.0214 |
| December 31, 2025 | 0.0394 |
| September 30, 2025 | 0.0125 |
| June 30, 2025 | 0.0102 |
| March 31, 2025 | 0.0269 |
| December 31, 2024 | 0.0171 |
| September 30, 2024 | 0.0119 |
| June 30, 2024 | 0.009 |
| March 31, 2024 | 0.0186 |
| December 31, 2023 | 0.0122 |
| September 30, 2023 | 0.0101 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.0054 |
| December 31, 2021 | 0.0049 |
| September 30, 2021 | 0.0126 |
| June 30, 2021 | 0.0088 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.0068 |
| December 31, 2020 | 0.0131 |
| September 30, 2020 | 0.0105 |
| June 30, 2020 | 0.0085 |
| March 31, 2020 | 0.0143 |
| December 31, 2019 | 0.0094 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0092 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 1.214 |
| September 30, 2018 | 0.9287 |
| June 30, 2018 | 0.6773 |
| March 31, 2018 | 0.4859 |
| December 31, 2017 | 2.547 |
| September 30, 2017 | 1.002 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -1.440 |
| March 31, 2016 | -1.008 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ionis Pharmaceuticals, Inc. | 4.978 |
| aTyr Pharma, Inc. | 0.2316 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 13.27M |
| Total Liabilities (Quarterly) | 6.449M |
| Shareholders Equity (Quarterly) | 6.822M |
| Current Ratio | 2.059 |
| Net Debt Paydown Yield | -0.13% |